Prognostic Value of Deep Learning-Mediated Treatment Monitoring in Lung Cancer Patients Receiving Immunotherapy

BACKGROUND: Checkpoint inhibitors provided sustained clinical benefit to metastatic lung cancer patients. Nonetheless, prognostic markers in metastatic settings are still under research. Imaging offers distinctive advantages, providing whole-body information non-invasively, while routinely available...

Descripción completa

Detalles Bibliográficos
Autores principales: Trebeschi, Stefano, Bodalal, Zuhir, Boellaard, Thierry N., Tareco Bucho, Teresa M., Drago, Silvia G., Kurilova, Ieva, Calin-Vainak, Adriana M., Delli Pizzi, Andrea, Muller, Mirte, Hummelink, Karlijn, Hartemink, Koen J., Nguyen-Kim, Thi Dan Linh, Smit, Egbert F., Aerts, Hugo J. W. L., Beets-Tan, Regina G. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962549/
https://www.ncbi.nlm.nih.gov/pubmed/33738253
http://dx.doi.org/10.3389/fonc.2021.609054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962549/
https://www.ncbi.nlm.nih.gov/pubmed/33738253
http://dx.doi.org/10.3389/fonc.2021.609054

Ejemplares similares